{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:17:01Z","timestamp":1790050621053,"version":"4.0.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,15]]},"DOI":"10.2146\/ajhp160585","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T16:55:40Z","timestamp":1512752140000},"page":"2037-2045","source":"Crossref","is-referenced-by-count":21,"title":["Antiviral treatment of BK virus viremia after kidney transplantation"],"prefix":"10.1093","volume":"74","author":[{"given":"Andrew D.","family":"Santeusanio","sequence":"first","affiliation":[{"name":"Mount Sinai Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E.","family":"Lukens","sequence":"additional","affiliation":[{"name":"Touro College of Pharmacy, New York, NY, and Mount Sinai Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Eun","sequence":"additional","affiliation":[{"name":"Mount Sinai Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041604412207800_b1-0742037","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.transproceed.2015.05.010","article-title":"BK virus nephropathy in kidney transplantation: an approach proposal and update on risk factors, diagnosis, and treatment","volume":"47","author":"Gonzalez","year":"2015","journal-title":"Transplant Proc"},{"key":"2019041604412207800_b2-0742037","doi-asserted-by":"crossref","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","article-title":"Seroepidemiology of human polyomaviruses","volume":"5","author":"Kean","year":"2009","journal-title":"PLoS Pathog"},{"key":"2019041604412207800_b3-0742037","first-page":"352","article-title":"Human polyoma virus (HPV)\u2014a significant pathogen in renal transplantation","volume":"15","author":"Mackenzie","year":"1978","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"2019041604412207800_b4-0742037","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041604412207800_b5-0742037","first-page":"245","article-title":"BK virus-associated nephropathy in kidney transplant recipients","volume":"10","author":"Garces","year":"2010","journal-title":"Ochsner J"},{"key":"2019041604412207800_b6-0742037","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"key":"2019041604412207800_b7-0742037","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"2019041604412207800_b8-0742037","volume-title":"Vistide (cidofovir) package insert","year":"2010"},{"key":"2019041604412207800_b9-0742037","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/tid.12014","article-title":"Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection","volume":"15","author":"Momper","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"2019041604412207800_b10-0742037","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1600-6143.2005.00980.x","article-title":"Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients","volume":"5","author":"Kuypers","year":"2005","journal-title":"Am J Transplant"},{"key":"2019041604412207800_b11-0742037","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/tid.12313","article-title":"Observations on the use of cidofovir for BK virus infection in renal transplantation","volume":"16","author":"Kuten","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2019041604412207800_b12-0742037","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.transproceed.2008.09.002","article-title":"Treatment of BK virus-associated nephropathy with cidofovir in renal transplantation","volume":"40","author":"Cabello","year":"2008","journal-title":"Transplant Proc"},{"key":"2019041604412207800_b13-0742037","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"2019041604412207800_b14-0742037","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00974-10","article-title":"1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells","volume":"54","author":"Rinaldo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041604412207800_b15-0742037","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2014.11.020","article-title":"Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation","volume":"65","author":"Papanicolaou","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2019041604412207800_b16-0742037","unstructured":"ClinicalTrials.gov . A randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase 3 study of the safety, tolerability, and efficacy of CMX001 for the prevention of cytomegalovirus infection in CMV-seropositive hematopoietic stem cell transplant recipients. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01769170 (accessed 2016 Oct 14)."},{"key":"2019041604412207800_b17-0742037","volume-title":"Arava (leflunomide) package insert","year":"2011"},{"key":"2019041604412207800_b18-0742037","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/eci.11.20","article-title":"Leflunomide in renal transplantation","volume":"7","author":"Chon","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"2019041604412207800_b19-0742037","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.transproceed.2004.04.077","article-title":"Polyomavirus BK infection in Greek renal transplant recipients","volume":"36","author":"Zavos","year":"2004","journal-title":"Transplant Proc"},{"key":"2019041604412207800_b20-0742037","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/ndt\/gfl032","article-title":"Remission of polyomavirus induced graft nephropathy treated with low-dose leflunomide","volume":"21","author":"Teschner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2019041604412207800_b21-0742037","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5414\/CNP69244","article-title":"A single center experience with BK virus nephropathy","volume":"69","author":"Ott","year":"2008","journal-title":"Clin Nephrol"},{"key":"2019041604412207800_b22-0742037","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.tp.0000181149.76113.50","article-title":"Treatment of renal allograft polyoma BK virus infection with leflunomide","volume":"81","author":"Josephson","year":"2006","journal-title":"Transplantation"},{"key":"2019041604412207800_b23-0742037","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.12531211","article-title":"Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection","volume":"7","author":"Krisl","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019041604412207800_b24-0742037","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation","volume":"20","author":"Faguer","year":"2007","journal-title":"Transplant Int"},{"key":"2019041604412207800_b25-0742037","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/TP.0b013e3181f2c94b","article-title":"Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy","volume":"90","author":"Guasch","year":"2010","journal-title":"Transplantation"},{"key":"2019041604412207800_b26-0742037","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-6143.2010.03400.x","article-title":"Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients","volume":"11","author":"Jordan","year":"2011","journal-title":"Am J Transplant"},{"key":"2019041604412207800_b27-0742037","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ajt.13083","article-title":"Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK","volume":"15","author":"Randhawa","year":"2015","journal-title":"Am J Transplant"},{"key":"2019041604412207800_b28-0742037","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant Proc"},{"key":"2019041604412207800_b29-0742037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"key":"2019041604412207800_b30-0742037","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1399-3046.2010.01384.x","article-title":"Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients","volume":"16","author":"Anyaegbu","year":"2012","journal-title":"Pediatr Transplant"},{"key":"2019041604412207800_b31-0742037","first-page":"528","article-title":"Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant","volume":"12","author":"Halim","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"2019041604412207800_b32-0742037","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial","volume":"9","author":"Lee","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019041604412207800_b33-0742037","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1001\/jama.2014.14721","article-title":"Levofloxacin for BK virus prophylaxis following kidney transplantation","volume":"312","author":"Knoll","year":"2014","journal-title":"JAMA"},{"key":"2019041604412207800_b34-0742037","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/TP.0b013e31826ec74e","article-title":"Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year","volume":"94","author":"Wojciechowski","year":"2012","journal-title":"Transplantation"},{"key":"2019041604412207800_b35-0742037","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2215\/CJN.08261109","article-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","volume":"5","author":"Gabardi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019041604412207800_b36-0742037","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/24\/2037\/28450427\/ajhp2037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T02:46:30Z","timestamp":1660099590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/24\/2037\/5103309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":36,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,12,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160585","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,15]]},"published":{"date-parts":[[2017,12,15]]}}}